Kimberly Babson
Company: Jazz Pharmaceuticals
Job title: Senior Director, Clinical Development, Neuroscience
Seminars:
Examining the Potential of FAAH Inhibition for PTSD and Evaluating a Promising FAAH Inhibitor in Initial Clinical Testing 9:00 am
Introduction to Jazz and pipeline Overview of scientific background on FAAH inhibition Overview of the study design for an ongoing Phase 2 study of JZP150 (FAAH inhibitor) for PTSDRead more
day: Conference Day Two
Workshop C: Expanding Neuropsychiatric Pipelines 9:00 am - 12:00 pm
This interactive session will showcase the latest advances to treat indications with considerably smaller drug markets to expand beyond more heavily researched therapeutic areas, such as schizophrenia and depression. Explore transdiagnostic approaches and novel research efforts to address these indications Collaboratively discuss what can be done to ensure greater chance of success of novel therapeutics…Read more
day: NON-PSYCHEDELIC R&D TRACK